|
US4634665A
(en)
|
1980-02-25 |
1987-01-06 |
The Trustees Of Columbia University In The City Of New York |
Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
|
|
US4399216A
(en)
|
1980-02-25 |
1983-08-16 |
The Trustees Of Columbia University |
Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
|
|
US5179017A
(en)
|
1980-02-25 |
1993-01-12 |
The Trustees Of Columbia University In The City Of New York |
Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
|
|
US4510245A
(en)
|
1982-11-18 |
1985-04-09 |
Chiron Corporation |
Adenovirus promoter system
|
|
US4740461A
(en)
|
1983-12-27 |
1988-04-26 |
Genetics Institute, Inc. |
Vectors and methods for transformation of eucaryotic cells
|
|
US5168062A
(en)
|
1985-01-30 |
1992-12-01 |
University Of Iowa Research Foundation |
Transfer vectors and microorganisms containing human cytomegalovirus immediate-early promoter-regulatory DNA sequence
|
|
EP0216846B2
(en)
|
1985-04-01 |
1995-04-26 |
Celltech Limited |
Transformed myeloma cell-line and a process for the expression of a gene coding for a eukaryotic polypeptide employing same
|
|
US4968615A
(en)
|
1985-12-18 |
1990-11-06 |
Ciba-Geigy Corporation |
Deoxyribonucleic acid segment from a virus
|
|
GB8601597D0
(en)
|
1986-01-23 |
1986-02-26 |
Wilson R H |
Nucleotide sequences
|
|
US4959455A
(en)
|
1986-07-14 |
1990-09-25 |
Genetics Institute, Inc. |
Primate hematopoietic growth factors IL-3 and pharmaceutical compositions
|
|
US4912040A
(en)
|
1986-11-14 |
1990-03-27 |
Genetics Institute, Inc. |
Eucaryotic expression system
|
|
US5750172A
(en)
|
1987-06-23 |
1998-05-12 |
Pharming B.V. |
Transgenic non human mammal milk
|
|
GB8717430D0
(en)
|
1987-07-23 |
1987-08-26 |
Celltech Ltd |
Recombinant dna product
|
|
GB8809129D0
(en)
|
1988-04-18 |
1988-05-18 |
Celltech Ltd |
Recombinant dna methods vectors and host cells
|
|
US5223409A
(en)
|
1988-09-02 |
1993-06-29 |
Protein Engineering Corp. |
Directed evolution of novel binding proteins
|
|
US5959177A
(en)
|
1989-10-27 |
1999-09-28 |
The Scripps Research Institute |
Transgenic plants expressing assembled secretory antibodies
|
|
US5633076A
(en)
|
1989-12-01 |
1997-05-27 |
Pharming Bv |
Method of producing a transgenic bovine or transgenic bovine embryo
|
|
US5427908A
(en)
|
1990-05-01 |
1995-06-27 |
Affymax Technologies N.V. |
Recombinant library screening methods
|
|
GB9015198D0
(en)
|
1990-07-10 |
1990-08-29 |
Brien Caroline J O |
Binding substance
|
|
ES2139598T3
(es)
|
1990-07-10 |
2000-02-16 |
Medical Res Council |
Procedimientos para la produccion de miembros de parejas de union especifica.
|
|
CA2095633C
(en)
|
1990-12-03 |
2003-02-04 |
Lisa J. Garrard |
Enrichment method for variant proteins with altered binding properties
|
|
EP1279731B1
(en)
|
1991-03-01 |
2007-05-30 |
Dyax Corporation |
Process for the development of binding mini-proteins
|
|
DE69233367T2
(de)
|
1991-04-10 |
2005-05-25 |
The Scripps Research Institute, La Jolla |
Bibliotheken heterodimerer rezeptoren mittels phagemiden
|
|
DE4122599C2
(de)
|
1991-07-08 |
1993-11-11 |
Deutsches Krebsforsch |
Phagemid zum Screenen von Antikörpern
|
|
CA2119930C
(en)
|
1991-09-23 |
2002-10-01 |
Hendricus R. J. M. Hoogenboom |
Production of chimeric antibodies - a combinatorial approach
|
|
WO1994006909A2
(en)
|
1992-09-18 |
1994-03-31 |
United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
A method of preventing tumor metastasis
|
|
PT804070E
(pt)
|
1993-03-09 |
2000-11-30 |
Genzyme Corp |
Isolamento de componentes de interesse a partir do leite.
|
|
US5827690A
(en)
|
1993-12-20 |
1998-10-27 |
Genzyme Transgenics Corporatiion |
Transgenic production of antibodies in milk
|
|
US5707624A
(en)
|
1994-06-03 |
1998-01-13 |
The Regents Of The University Of Michigan |
Treatment of Kaposi's sarcoma by inhibition of scatter factor
|
|
US6046037A
(en)
|
1994-12-30 |
2000-04-04 |
Hiatt; Andrew C. |
Method for producing immunoglobulins containing protection proteins in plants and their use
|
|
US5686292A
(en)
|
1995-06-02 |
1997-11-11 |
Genentech, Inc. |
Hepatocyte growth factor receptor antagonist antibodies and uses thereof
|
|
US6214344B1
(en)
|
1995-06-02 |
2001-04-10 |
Genetech, Inc. |
Hepatocyte growth factor receptor antagonists and uses thereof
|
|
DE69739856D1
(de)
|
1996-07-03 |
2010-06-02 |
Genentech Inc |
Agonisten für den rezeptor des hepatozyten-wachstumsfaktors und deren anwendungen
|
|
GB2339430A
(en)
|
1997-05-21 |
2000-01-26 |
Biovation Ltd |
Method for the production of non-immunogenic proteins
|
|
EP1105427A2
(en)
|
1998-08-17 |
2001-06-13 |
Abgenix, Inc. |
Generation of modified molecules with increased serum half-lives
|
|
CA2342967A1
(en)
|
1998-12-08 |
2000-06-15 |
Biovation Limited |
Modifying protein immunogenicity
|
|
US6517529B1
(en)
|
1999-11-24 |
2003-02-11 |
Radius International Limited Partnership |
Hemodialysis catheter
|
|
DK1583830T3
(da)
|
2003-01-07 |
2007-01-15 |
Symphogen As |
Fremgangsmåde til fremstilling af rekombinante polyklonale proteiner
|
|
ITMI20031127A1
(it)
|
2003-06-05 |
2004-12-06 |
Uni Degli Studi Del Piemont E Orientale Am |
Anticorpi anti-hgf-r e loro uso
|
|
HN2004000285A
(es)
|
2003-08-04 |
2006-04-27 |
Pfizer Prod Inc |
ANTICUERPOS DIRIGIDOS A c-MET
|
|
TWI333977B
(en)
|
2003-09-18 |
2010-12-01 |
Symphogen As |
Method for linking sequences of interest
|
|
EP1778270A4
(en)
|
2004-05-05 |
2009-09-02 |
Merrimack Pharmaceuticals Inc |
BIS-SPECIFIC BINDER FOR MODULATING BIOLOGICAL ACTIVITY
|
|
BRPI0513666A
(pt)
|
2004-08-05 |
2008-05-13 |
Genentech Inc |
anticorpos, anticorpos anti c-met humanizados, método de inibição de proliferação celular de c-met ativado, método de modulação de uma doença associada com descontrole de sinalização de hgf/c-met, método para o tratamento de um sujeito com cáncer, método para o tratamento de um distúrbio proliferativo, ácido nucléico, célula hospedeira e composição
|
|
MX2007011652A
(es)
|
2005-03-25 |
2007-11-14 |
Genentech Inc |
Metodos y composiciones para modular c-met hiperestabilizado.
|
|
ATE541584T1
(de)
|
2005-11-16 |
2012-02-15 |
Fariba Nayeri |
Verfahren zur hemmung von krebsbildung und/oder metastasen bei einer person durch endogene c-met- liganden und -hemmer
|
|
CA2638889C
(en)
|
2006-02-06 |
2015-06-02 |
Metheresis Translational Research S.A. |
Anti-met monoclonal antibody, fragments and vectors thereof, for the treatment of tumors and corresponding products
|
|
WO2007119447A1
(ja)
|
2006-03-20 |
2007-10-25 |
Seikagaku Corporation |
関節リウマチの処置剤
|
|
ES2386738T3
(es)
|
2006-03-30 |
2012-08-28 |
Novartis Ag |
Composiciones y métodos de uso para anticuerpos de C-MET
|
|
US8039598B2
(en)
|
2007-01-19 |
2011-10-18 |
Van Andel Research Institute |
Met fab and SCFV fragments
|
|
DK2152872T3
(da)
|
2007-05-25 |
2010-12-06 |
Symphogen As |
Fremgangsmåde til fremstilling af et rekombinant polyklonalt protein
|
|
EP2014681A1
(en)
|
2007-07-12 |
2009-01-14 |
Pierre Fabre Medicament |
Novel antibodies inhibiting c-met dimerization, and uses thereof
|
|
US7892770B2
(en)
|
2007-08-24 |
2011-02-22 |
Van Andel Research Institute |
Monoclonal antibody which binds cMet (HGFR) in formalin-fixed and paraffin-embedded tissues and related methods
|
|
MX2010011293A
(es)
|
2008-04-23 |
2010-12-20 |
Symphogen As |
Metodos para producir una proteina policlonal.
|
|
WO2009142738A2
(en)
*
|
2008-05-21 |
2009-11-26 |
Oncomed Pharmaceuticals, Inc. |
Compositions and methods for diagnosing and treating cancer
|
|
US10421819B2
(en)
*
|
2008-10-06 |
2019-09-24 |
Minerva Biotechnologies Corporation |
MUC1* antibodies
|
|
PA8849001A1
(es)
*
|
2008-11-21 |
2010-06-28 |
Lilly Co Eli |
Anticuerpos de c-met
|
|
EP2545077B1
(en)
|
2010-03-10 |
2018-10-31 |
Genmab A/S |
Monoclonal antibodies against c-met
|
|
WO2012059857A2
(en)
|
2010-11-01 |
2012-05-10 |
Symphogen A/S |
Pan-her antibody composition
|
|
CN103562223B
(zh)
*
|
2010-11-03 |
2017-02-22 |
阿尔金-X有限公司 |
抗c‑Met抗体
|